These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6281147)

  • 1. [Inhibition of acid secretion with substituted benzimidazole. A new principle in ulcer therapy?].
    Simon B; Müller P; Dammann HG; Kather H
    Fortschr Med; 1982 Feb; 100(5):159-60. PubMed ID: 6281147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE; Jensen RT; Gardner JD
    Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
    Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
    J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor.
    Kato S; Kitamura M; Korolkiewicz RP; Takeuchi K
    Br J Pharmacol; 1998 Mar; 123(5):839-46. PubMed ID: 9535011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
    Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
    Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.
    Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E
    Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological basis of omeprazole therapy.
    Sachs G; Wallmark B
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired gastric acid secretion in mast cell-deficient mice.
    Stechschulte DJ; Morris DC; Jilka RL; Stechschulte DJ; Dileepan KN
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G41-7. PubMed ID: 1695487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine dependence of pentagastrin-stimulated gastric acid secretion in rats.
    Shankley NP; Welsh NJ; Black JW
    Yale J Biol Med; 1992; 65(6):613-9. PubMed ID: 1285198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisecretory actions of Baccharis trimera (Less.) DC aqueous extract and isolated compounds: analysis of underlying mechanisms.
    Biondo TM; Tanae MM; Coletta ED; Lima-Landman MT; Lapa AJ; Souccar C
    J Ethnopharmacol; 2011 Jun; 136(2):368-73. PubMed ID: 21575703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric antisecretory and antiulcer/cytoprotective effects of 2-cyano-3-(ethylthio-3-methylthio)-2-propenoic acid methyl ester.
    Borella LE; DiJoseph JF
    Arzneimittelforschung; 1989 May; 39(5):598-601. PubMed ID: 2547390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of drugs influencing gastric secretion on the quantitative histological distribution of cyclic adenosine 3':5'-monophosphate in the rat stomach.
    Katsumata Y; Glick D
    Gastroenterology; 1975 Aug; 69(2):409-15. PubMed ID: 168122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.